Bo Tang
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Molecular Biology top 10%
- RNA modifications and cancer 12
- Ubiquitin and proteasome pathways 6
- Receptor Mechanisms and Signaling 3
- Genetics top 10%
- Biochemistry top 10%
-
- Ferroptosis and cancer prognosis 9
-
- Lymphoma Diagnosis and Treatment 4
-
- Cancer-related Molecular Pathways 3
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Blood (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Bo Tang
59 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 384
- Molecular Biology 791
- Immunology 142
- Genetics 179
- Biochemistry 43
Countries citing papers authored by Bo Tang
This map shows the geographic impact of Bo Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Tang more than expected).
Fields of papers citing papers by Bo Tang
This network shows the impact of papers produced by Bo Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Tang. The network helps show where Bo Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 10 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 30 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 5 | |
| 11 | 2018 | 20 | |
| 12 | 2017 | 28 | |
| 13 | 2015 | 19 | |
| 14 | 2014 | 195 | |
| 15 | 2011 | 100 | |
| 16 | 2008 | 13 | |
| 17 | 2008 | 27 | |
| 18 | 2008 | 48 | |
| 19 | 2003 | 17 | |
| 20 | 2002 | 13 |
About Bo Tang
Bo Tang is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Ferroptosis and cancer prognosis (9 papers), Ubiquitin and proteasome pathways (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer-related Molecular Pathways (3 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Cancer Research (384 citations), Molecular Biology (791 citations) and Immunology (142 citations). Bo Tang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Xueying Sun, Jian Xu, Yu Hu, Shaozhong Kang, Ling Tong, Lu Zhang, Jun Deng, Li Zhang, Qiuling Wu and Xiaobo Wang. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.